Syneron Medical Ltd. (ELOS-Q) Stock Predictions - Stockchase
WATCH LIST
8
Syneron Medical Ltd. (ELOS-Q)

ON STOCKCHASE SINCE Feb 2005

Intense light product for hair removal,wrinkles, etc.

Gone private (July 2017)

biotechnology/pharmaceutical

Syneron Medical Ltd.

ELOS-Q

0 watching          
Join the Discussion

Syneron Medical Ltd. (ELOS-Q) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about ELOS-Q



  • All
  • Filtered
Signal Opinion Expert
WATCH
Have about $6 of cash per share. Earnings should be $1.60. Missed 2 quarters in a row and the stock took a hit. Some key people have left. Has created doubt, but the trend in the industry is very good. He sold his holdings. Would buy if they start growing again.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have about $6 of cash per share. Earnings should be $1.60. Missed 2 quarters in a row and the stock took a hit. Some key people have left. Has created doubt, but the trend in the industry is very good. He sold his holdings. Would buy if they start growing again.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$20.550
Owned Owned
No

PAST TOP PICK
(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Feb 15/06. Down 27%.) Disappointed two quarters in a row. Forward expectations by US analysts have dropped. Have sold some shares. The industry is doing well. He'll wait for one more quarter.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$19.400
Owned Owned
Yes

WATCH
Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Still likes it, but there are some worrisome things. Have lost some top level management. The earnings are growing, have a great balance sheet and lots of cash. Waiting to see what the next quarter brings. Trading around 10 X earnings which is not expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$26.160
Owned Owned
Yes

PAST TOP PICK
(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Feb 15/06. Up 6%.) The beauty treatment sector is doing very well. Still likes.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$29.400
Owned Owned
Yes

TOP PICK
Syneron Medical Ltd.(ELOS-Q) 

February 15, 2006

Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Recently, the stock was hit pretty hard because of lower than expected earnings forecast. Thinks they will make $2/2.20 a share in ’06. They have $5 in cash per share. Not very expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$27.830
Owned Owned
Yes

TOP PICK
Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Sells machines to health care clinics. Just got approval from the FDA for a cellulite product. Expects great demand. Earnings have been rising very rapidly. Low multiples.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$32.060
Owned Owned
Yes

PAST TOP PICK
(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(A Top Pick Feb3/05. Up 20%.) Still likes. Trying to get approval on a new product. Analysts forcast for next year is $1.60 but he believes it could be as high as $2.50/3.00.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$34.860
Owned Owned
Yes

TOP PICK
Syneron Medical Ltd.(ELOS-Q) 

February 3, 2005

Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Health and cosmetic industry is growing very strong. Company is very innovative. In '04, their earnings grew about 100%. Have $3 cash per share. Will be launching a new product for sunlight. Trades at 25 X current earnings.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$29.000
Owned Owned
Yes

Showing 1 to 8 of 8 entries
Successfully Saved Company
Successfully Saved Company